Abstract
Purpose
To assess the reliability and the diagnostic performance of a novel CE (European Conformity)-marked and FDA (Food and Drug Administration)-cleared dot patient self-monitoring test (Alleye, Oculocare medical Inc.) for the detection and characterization of metamorphopsia in age-related macular degeneration (AMD).
Methods
Three consecutive tests were performed in 63 wet AMD, 26 dry AMD, and 19 age-matched healthy eyes. In addition, the test was performed in 34 young healthy eyes. The mean Alleye score and standard deviations (SDs) were calculated for each eye and group. We compared and tested healthy with dry and wet AMD eyes and assessed the extent to which the test discriminated between healthy subjects and patients with dry and wet AMD using the area under the receiver operating characteristic curve (AUC).
Results
The mean (SD) Alleye score was 49.5 (16.1) in wet AMD eyes, 62.1 (22.5) in dry AMD eyes, 69.8 (10.2) in age-matched healthy eyes, and 85.3 (10.0) in young healthy subjects. Compared to age-matched healthy subjects, the AUC (95% confidence interval) to detect wet AMD was 0.845 (0.759–0.932), and 0.660 (0.520–0.799) to discriminate between dry and wet AMD. Compared to young healthy subjects, the AUC to detect dry AMD was 0.799 (0.675–0.923), and 0.969 (0.940–0.997) to detect wet AMD.
Conclusions
This is the first assessment of Alleye in clinical practice. The test is highly accurate to detect wet AMD and reasonably accurate to classify dry vs. wet AMD. Data from longitudinal monitoring and its role in the therapeutic management of AMD is warranted.
Similar content being viewed by others
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, et al. Randomized trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) study. Ophthalmology. 2014;121:535–44.
Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98:1144–67.
Amsler M. L’Examen qualitatif de la fonction maculaire. Ophthalmologica. 1947;114:248–61.210.1159/000300476.
Westheimer G. Editorial: visual acuity and hyperacuity. Invest Ophthalmol. 1975;14:570–2.
Simunovic MP. Metamorphopsia and its quantification. Retina. 2015;35:1285–91.
Faes L, Bodmer NS, Bachmann LM, Thiel MA, Schmid MK. Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis. Eye. 2014;28:788–96.
Crossland M, Rubin G. The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol. 2007;91:391–3.
Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol. 1986;104:513–4.
Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, et al. Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design—HOME Study report number 1. Conte Clin Trials. 2014;37:294–300.
Schwartz R, Loewenstein A. Early detection of age related macular degeneration: current status. Int J Retin Vitr. 2015;1:20.
Lienhard KR, Legner C. Principles in the design of mobile medical apps: guidance for those who care. In: Proceedings of the 13th International Conference on Wirtschaftsinformatik (WI), St Gallen, Switzerland; 2017.
Geisler WS. Physical limits of acuity and hyperacuity. J Opt Soc Am A. 1984;1:775–82.
Keane PA, de Salvo G, Sim DA, Goverdhan S, Agrawal R, Tufail A. Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration. Clin Ophthalmol. 2015;9:353–66.
Schmid MK, Faes L, Bachmann LM, Thiel MA. Accuracy of a self-monitoring test for identification and monitoring of age-related macular degeneration: a diagnostic case–control study. Open Ophthalmol J. 2018;12:19–28.
Kaiser PK, Wang YZ, He YG, Weisberger A, Wolf S, Smith CH. Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study. Retina. 2013;33:1863–70.
Wang YZ, He YG, Mitzel G, Zhang S, Bartlett M. Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy. Invest Ophthalmol Vis Sci. 2013;54:5497–505.
Wang YZ, Wilson E, Locke KG, Edwards AO. Shape discrimination in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2002;43:2055–62.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
LMB, MAT, KL, and MKS are founders of Oculocare medical Inc., which develops innovative products in eye care, such as the self-monitoring test described in this paper. The other authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schmid, M.K., Thiel, M.A., Lienhard, K. et al. Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration. Eye 33, 1584–1589 (2019). https://doi.org/10.1038/s41433-019-0455-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-019-0455-6
This article is cited by
-
Sustainability and minimization of carbon footprint in ophthalmology: what can we change in the outpatient clinic routine?
Eye (2025)
-
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Eye (2025)
-
Telemedicine in ophthalmology
Wiener Medizinische Wochenschrift (2025)
-
Mobile Apps and Visual Function Assessment: A Comprehensive Review of the Latest Advancements
Ophthalmology and Therapy (2025)
-
Knowledge, attitudes, and practices of patients with age-related macular degeneration (AMD) towards Anti-VEGF treatment under one-stop intravitreal injection model
Scientific Reports (2024)